000 01399 a2200421 4500
005 20250513133531.0
264 0 _c19980211
008 199802s 0 0 eng d
022 _a0022-3565
040 _aNLM
_beng
_cNLM
100 1 _aBarnette, M S
245 0 0 _aSB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions.
_h[electronic resource]
260 _bThe Journal of pharmacology and experimental therapeutics
_cJan 1998
300 _a420-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents
_xpharmacology
650 0 4 _aCyclohexanecarboxylic Acids
_xpharmacology
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aGastric Acid
_xmetabolism
650 0 4 _aHumans
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aNitriles
650 0 4 _aPhosphodiesterase Inhibitors
_xpharmacology
650 0 4 _aPyrrolidinones
_xpharmacology
650 0 4 _aRabbits
650 0 4 _aRolipram
700 1 _aChristensen, S B
700 1 _aEssayan, D M
700 1 _aGrous, M
700 1 _aPrabhakar, U
700 1 _aRush, J A
700 1 _aKagey-Sobotka, A
700 1 _aTorphy, T J
773 0 _tThe Journal of pharmacology and experimental therapeutics
_gvol. 284
_gno. 1
_gp. 420-6
999 _c9404570
_d9404570